Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanoparticle-based fluoride solution for dentin hypersensitivity
RBR-10svdw4cRecruiting
- Sponsor
- Anhanguera-UNIDERP
- Start
- Aug 2024
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, triple-blind trial of Gluma Desensitizer in Dentinal hypersensitivity (DH) (2 arms), sponsored by Anhanguera-UNIDERP. Started Aug 2024; status: recruiting.
02
Drugs
Gluma Desensitizer
03
Conditions
Dentinal hypersensitivity (DH)
Beyond the preview
Go deeper on RBR-10svdw4c.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-10svdw4c.